Antipodes Partners LTD Ideaya Biosciences, Inc. Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 770 shares of IDYA stock, worth $24,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
770Holding current value
$24,747% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IDYA
# of Institutions
242Shares Held
82.2MCall Options Held
509KPut Options Held
103K-
Black Rock Inc. New York, NY6.81MShares$219 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.55MShares$211 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.43MShares$207 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.92MShares$158 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.63MShares$149 Million0.24% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.54B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...